Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)
Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)
The Increasing Number of Therapeutic Drugs, Need for Immediate Relief Drive the Growth of Parenteral and Transdermal Excipients
RELEASE DATE
16-Jul-2014
16-Jul-2014
REGION
North America
North America
Research Code: NE52-01-00-00-00
SKU: CM00110-NA-MR_00427
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
CM00110-NA-MR_00427
Description
This study covers in detail the parenteral and transdermal excipients used in the pharmaceutical industry. We have observed that the growing prescription of biologicals that are almost exclusively administered by parenteral routes drives the market growth. Convenience and immediate therapeutic benefits have spurred the growth of transdermal products, which has in-turn increased transdermal excipients. The benefits provided by both product forms are expected to gain market share in the next five years.
Table of Contents
Executive Summary
Research Scope and Methodology
Market Overview—Parenteral Excipients
Market Overview—Transdermal Excipients
Market Overview—Parenteral Excipient Types/Classification
Market Overview—Parenteral Excipient Functions
Market Overview—Transdermal Excipient Types/ Classification
Market Overview—Transdermal Excipients Functions
Advancement in Liquid Dosage Excipients—Value Chain
Parenteral Excipients Segment—Drivers and Restraints
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Transdermal Excipients Segment—Drivers and Restraints
Drivers Explained
Drivers Explained (continued)
Restraints Explained
Market Engineering Measurements
Total Transdermal and Parenteral Excipients Market—Revenue and Volume Forecast
Revenue and Volume Forecast Discussion
Parenteral Excipients Segment—Pricing by Product Type
Parenteral Excipients Segment—Pricing by Product Type (continued)
Transdermal Excipients Segment—Pricing by Product Type
Transdermal Excipients Segment—Pricing by Product Type (continued)
Transdermal and Parenteral Excipients Market—Pricing by Product Type Discussion
Excipients for Parenteral Products—Suppliers
Excipients for Parenteral Products—Suppliers (continued)
Excipients for Transdermal Products—Suppliers
Market Share Analysis—Ranking of Suppliers for Selected Excipients
Competitive Analysis—Excipients in Marketed Parenteral Products
Competitive Analysis—Excipients in Marketed Parenteral Products (continued)
Competitive Analysis—Excipients in Marketed Parenteral Products (continued)
Competitive Analysis—Excipients in Marketed Transdermal Products—Technology Overview
Competitive Analysis—Excipients in Marketed Transdermal Products—Technology Overview (continued)
Transdermal and Parenteral Excipients Market—Competitive Factors
Transdermal and Parenteral Excipients Market—Competitive Factors Discussion
Transdermal and Parenteral Excipients Market—Competitive Factors Discussions (continued)
Company Profile of Key Market Participants—BASF
Company Profile of Key Market Participants—BASF (continued)
Company Profile of Key Market Participants—Dow Chemicals
Company Profile of Key Market Participants—Dow Chemicals (continued)
Company Profile of Key Market Participants—Gattefosse
Company Profile of Key Market Participants—Gattefosse (continued)
Parenteral Excipients Segment Breakdown
Excipients for Parenteral Products
Excipients for Parenteral Products—Technology Overview
Excipients for Parenteral Products—Technology Overview (continued)
Parenteral Excipients Segment—Market Engineering Measurement
Parenteral Excipients Segment—Revenue and Volume Forecast
Revenue and Volume Forecast Discussion
Parenteral Excipients Segment—Percent Volume by Excipient Type
Percent Volume by Excipient Type Discussion
Percent Volume by Excipient Type Discussion (continued)
Transdermal Excipients Segment Breakdown
Excipients for Transdermal Products—Technology Overview
Excipients for Transdermal Products—Technology Overview (continued)
Excipients for Transdermal Products—Technology Overview (continued)
Market Engineering Measurements—Transdermal Excipients Segment
Transdermal Excipients Segment—Revenue and Volume Forecast
Revenue and Volume Forecast Discussion
Transdermal Excipients Segment—Percent Volume by Excipient Type
Percent Volume by Excipient Type Discussion
Percent Volume by Excipient Type Discussion (continued)
Transdermal and Parenteral Excipients Market—Regional Breakdown
Transdermal and Parenteral Excipients Market—Regional Breakdown Discussion
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
This study covers in detail the parenteral and transdermal excipients used in the pharmaceutical industry. We have observed that the growing prescription of biologicals that are almost exclusively administered by parenteral routes drives the market growth. Convenience and immediate therapeutic benefits have spurred the growth of transdermal products, which has in-turn increased transdermal excipients. The benefits provided by both product forms are expected to gain market share in the next five years.
No Index | Yes |
---|---|
Podcast | No |
Author | Nandhini Rajagopal |
Industries | Chemicals and Materials |
WIP Number | NE52-01-00-00-00 |
Is Prebook | No |